2026-2030年全球藥物濫用檢測市場

全球藥物濫用檢測市場預計將在 2025 年至 2030 年間成長至 12.559 億美元，預測期內複合年成長率為 4.9%。

這份關於全球藥物濫用檢測市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：受監管行業中更嚴格的職場藥物篩檢需求、醫療保健系統不斷擴大的藥物濫用監測工作，以及法醫學毒理學在刑事司法框架內日益廣泛的應用。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場數據及區域分析，以及供應商格局。報告包含歷史數據和預測數據。

該研究指出，人工智慧驅動的毒理學數據分析平台的日益普及將成為未來幾年全球藥物濫用檢測市場成長的主要驅動力之一。此外，口腔液檢測方法的推廣以及基於雲端的檢測資訊管理系統的整合預計也將產生顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球藥物濫用檢測市場
• 產品細分市場分析，2020-2024 年
• 2020年至2024年最終用戶細分市場分析
• 2020-2024年基於技術的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球藥物濫用檢測市場
• 地緣政治衝突對全球藥物濫用檢測市場的影響。

第7章：五力分析

第8章 市場區隔：依產品

• 比較：按產品
• 裝置
• 消耗品
• 市場機會：依產品分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院和診所
• 診斷檢查室
• 職場
• 法醫科學研究所
• 其他
• 市場機會：依最終用戶分類

第10章 市場區隔：依技術分類

• 比較：按技術
• 免疫檢測
• 層析法
• 質譜分析
• 其他
• 市場機會：依技術分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 中斷狀況
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• Beckman Coulter Inc.
• Bio Rad Laboratories Inc.
• Dragerwerk AG and Co. KGaA
• F. Hoffmann La Roche Ltd.
• Laboratory Holdings Inc.
• LGC Ltd.
• Meridian Bioscience Inc.
• OraSure Technologies Inc.
• Quest Diagnostics Inc.
• QuidelOrtho Corp.
• Randox Laboratories Ltd.
• Siemens Healthineers AG
• Sonic Healthcare Ltd.
• Thermo Fisher Scientific Inc.

第16章附錄

The global drugs of abuse testing market is forecasted to grow by USD 1255.9 mn during 2025-2030, accelerating at a CAGR of 4.9% during the forecast period. The report on the global drugs of abuse testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing workplace drug screening requirements across regulated industries, growing substance misuse surveillance initiatives in healthcare systems, expanding forensic toxicology applications in criminal justice frameworks.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global drugs of abuse testing market is segmented as below:

By Product

• Instruments
• Consumables

By End-User

• Hospitals and clinics
• Diagnostic laboratories
• Workplaces
• Forensic laboratories
• Others

By Technology

• Immunoassay
• Chromatography
• Mass spectrometry
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the advancing adoption of ai-enabled toxicology data interpretation platforms as one of the prime reasons driving the global drugs of abuse testing market growth during the next few years. Also, increasing shift toward oral fluid testing methodologies and evolving integration of cloud-based laboratory information management systems will lead to sizable demand in the market.

The report on the global drugs of abuse testing market covers the following areas:

• Global drugs of abuse testing market sizing
• Global drugs of abuse testing market forecast
• Global drugs of abuse testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global drugs of abuse testing market vendors that include Abbott Laboratories, Aegis Sciences Corporation, Alfa Scientific Designs Inc, Beckman Coulter Inc., Bio Rad Laboratories Inc., Clinical Reference Laboratory, Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co., Laboratory Holdings Inc., LGC Ltd., Lifeloc Technologies Inc., Meridian Bioscience Inc., Omega Laboratories Inc., OraSure Technologies Inc., Phamatech Inc., Premier Biotech Inc., Quest Diagnostics Inc., QuidelOrtho Corp., Randox Laboratories Ltd., Siemens Healthineers AG, Sonic Healthcare Ltd., Thermo Fisher Scientific Inc.. Also, the global drugs of abuse testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Drugs Of Abuse Testing Market 2020 - 2024
  • Historic Market Size - Data Table on Global Drugs Of Abuse Testing Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global drugs of abuse testing market
• 6.2 Impact of geopolitical conflicts on global drugs of abuse testing market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Instruments - Market size and forecast 2025-2030
• 8.4 Consumables - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals and clinics - Market size and forecast 2025-2030
• 9.4 Diagnostic laboratories - Market size and forecast 2025-2030
• 9.5 Workplaces - Market size and forecast 2025-2030
• 9.6 Forensic laboratories - Market size and forecast 2025-2030
• 9.7 Others - Market size and forecast 2025-2030
• 9.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 Immunoassay - Market size and forecast 2025-2030
• 10.4 Chromatography - Market size and forecast 2025-2030
• 10.5 Mass spectrometry - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing workplace drug screening requirements across regulated industries
  • Growing substance misuse surveillance initiatives in healthcare systems
  • Expanding forensic toxicology applications in criminal justice frameworks
• 13.2 Market challenges
  • Regulatory compliance complexity across multi-jurisdiction testing environments
  • Sample adulteration and result manipulation risks in screening programs
  • Reimbursement limitations affecting advanced testing adoption
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Advancing adoption of AI-enabled toxicology data interpretation platforms
  • Increasing shift toward oral fluid testing methodologies
  • Evolving integration of cloud-based laboratory information management systems

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 15.6 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.7 Dragerwerk AG and Co. KGaA
  • Dragerwerk AG and Co. KGaA - Overview
  • Dragerwerk AG and Co. KGaA - Business segments
  • Dragerwerk AG and Co. KGaA - Key offerings
  • Dragerwerk AG and Co. KGaA - Segment focus
  • SWOT
• 15.8 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.9 Laboratory Holdings Inc.
  • Laboratory Holdings Inc. - Overview
  • Laboratory Holdings Inc. - Business segments
  • Laboratory Holdings Inc. - Key offerings
  • Laboratory Holdings Inc. - Segment focus
  • SWOT
• 15.10 LGC Ltd.
  • LGC Ltd. - Overview
  • LGC Ltd. - Product / Service
  • LGC Ltd. - Key offerings
  • SWOT
• 15.11 Meridian Bioscience Inc.
  • Meridian Bioscience Inc. - Overview
  • Meridian Bioscience Inc. - Product / Service
  • Meridian Bioscience Inc. - Key offerings
  • SWOT
• 15.12 OraSure Technologies Inc.
  • OraSure Technologies Inc. - Overview
  • OraSure Technologies Inc. - Business segments
  • OraSure Technologies Inc. - Key offerings
  • OraSure Technologies Inc. - Segment focus
  • SWOT
• 15.13 Quest Diagnostics Inc.
  • Quest Diagnostics Inc. - Overview
  • Quest Diagnostics Inc. - Business segments
  • Quest Diagnostics Inc. - Key offerings
  • Quest Diagnostics Inc. - Segment focus
  • SWOT
• 15.14 QuidelOrtho Corp.
  • QuidelOrtho Corp. - Overview
  • QuidelOrtho Corp. - Business segments
  • QuidelOrtho Corp. - Key offerings
  • QuidelOrtho Corp. - Segment focus
  • SWOT
• 15.15 Randox Laboratories Ltd.
  • Randox Laboratories Ltd. - Overview
  • Randox Laboratories Ltd. - Product / Service
  • Randox Laboratories Ltd. - Key offerings
  • SWOT
• 15.16 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.17 Sonic Healthcare Ltd.
  • Sonic Healthcare Ltd. - Overview
  • Sonic Healthcare Ltd. - Business segments
  • Sonic Healthcare Ltd. - Key offerings
  • Sonic Healthcare Ltd. - Segment focus
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations